Process for reducing the chlorine content of organotetraphosphites

US10011619B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10011619-B2
Application numberUS-201615363746-A
CountryUS
Kind codeB2
Filing dateNov 29, 2016
Priority dateDec 3, 2015
Publication dateJul 3, 2018
Grant dateJul 3, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Universally usable process for reducing the chlorine content of organotetraphosphites.

First claim

Opening claim text (preview).

The invention claimed is: 1. Process for reducing the chlorine content in an organotetraphosphite of one of the general formulae I and II: where R 1 , R 2 , R 3 , R 4 are each independently selected from: —H, —(C 1 -C 12 )-alkyl; V and W are each independently selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, —(C 1 -C 12 )-heteroalkyl, —(C 4 -C 20 )-aryl, —(C 4 -C 20 )-aryl-(C 1 -C 12 )-alkyl, —(C 4 -C 20 )-aryl-O—(C 1 -C 12 )-alkyl, —(C 1 -C 12 )-alkyl-(C 4 -C 20 )-aryl, —(C 4 -C 20 )-aryl-COO—(C 1 -C 12 )-alkyl, —(C 4 -C 20 )-aryl-CONH—(C 1 -C 12 )-alkyl, —(C 4 -C 20 )-aryl-CON[(C 1 -C 12 )-alkyl] 2 , -(C 4 -C 20 -heteroaryl, —(C 4 -C 20 )-heteroaryl-(C 1 -C 12 )-alkyl, —(C 3 -C 12 )-cycloalkyl, —(C 3 -C 12 )-cycloalkyl-(C 1 -C 12 )-alkyl, —(C 3 -C 12 )-heterocycloalkyl, —(C 3 -C 12 )-heterocycloalkyl-(C 1 -C 12 )-alkyl, —CO—(C 1 -C 12 )-alkyl, —CO—(C 4 -C 20 )-aryl, —CO—(C 4 -C 20 )-heteroalkyl, —(C 4 -C 20 )-aryl-CO—(C 1 -C 12 )-alkyl, —(C 4 -C 20 )-aryl-CO—(C 4 -C 20 )-aryl; X and Y are each independently selected from O and N; where, in the case that X is O, n=1, and, in the case that Y is O, m=1, and, in the case that X is N, n=1 or 2, and, in the case that Y is N, m=1 or 2; Z is selected from: —(C 1 -C 14 )-alkyl- , —(C 4 -C 20 )-aryl-, —(C 4 -C 20 )-aryl-(C 1 -C 12 )- alkyl-, —(C 1 -C 14 )-heteroalkyl-, —(C 4 -C 20 )-heteroaryl-, —CO—(C 4 -C 14 )-heteroaryl-, —CO—(C 4 -C 20 )-aryl-, —(C 3 -C 12 )-cycloalkyl-, —(C 3 -C 12 )-heterocycloalkyl-, —(C 4 -C 20 )-aryl-CO—(C 4 -C 20 )-aryl-, —(C 1 -C 14 )-alkyl-O—(C 1 -C 14 )-alkyl-; where the alkyl, heteroalkyl, cycloalkyl, heterocycloalkyl, aryl and heteroaryl groups mentioned are optionally mono- or polysubstituted; comprising the following process steps: a) contacting the organotetraphosphite with a solution comprising at least one solvent and at least one base, where the at least one solvent is selected from aromatics, alcohols, acetone, ethyl acetate, acetonitrile and ethers, and where the at least one base is selected from amine bases, alkoxides, pyridine, pyridine derivatives, N-methyl-2-pyrrolidone, triethylamine and triethanolamine, b) adjusting the temperature to a value in the range from −20° C. to +15° C., c) removing the purified organotetraphosphite. 2. Process according to claim 1 , wherein the at least one solvent is selected from acetonitrile, ethyl acetate, ethanol, propanol, toluene. 3. Process according to claim 1 , wherein the solution with which the organotetraphosphite is contacted in step a) contains, as well as the at least one solvent and the at least one base, also max. 5% water based on the solvent content. 4. Process according to claim 1 , wherein the at least one base is selected from triethylamine and dimethylaininobutane. 5. Process according to claim 1 , where X and Y are O. 6. Process according to claim 1 , where X and Y are N. 7. Process according to claim 1 , where V and W are each independently selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, —(C 4 -C 20 )-aryl, —(C 4 -C 20 )-aryl-(C 1 -C 12 )-alkyl, —(C 4 -C 20 )-aryl-O—(C 1 -C 12 )-alkyl, —(C 1 -C 12 )-alkyl-(C 4 -C 20 )-aryl, —(C 4 -C 20 )-aryl-COO—(C 1 -C 12 )-alkyl. 8. Process according to claim 1 , where V and W are, or just one of the substituents V and W is, where R 5 , R 6 , R 7 , R 8 , R 9 are independently selected from —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, -phenyl, —COO—(C 1 -C 12 )-alkyl. 9. Process according to claim 1 , where Z is selected from: where R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 are each independently selected from: —H, —(C 1 -C 12 )-alkyl, —O—(C 1 -C 12 )-alkyl, —O—(C 6 -C 20 )-aryl, —(C 6 -C 20 )-aryl, -halogen (such as Cl, F, Br, I), COO—(C 1 -C 12 )-alkyl, CONH—(C 1 -C 12 )-alkyl, —(C 6 -C 20 )-aryl-CON[(C 1 -C 12 )-alkyl] 2 , —CO—(C 1 -C 12 )-alkyl, —CO—(C 6 -C 20 )-aryl, —COOH, —OH, —SO 3 H, —SO 3 Na, —NO 2 , —CN, —NH 2 , —N[(C 1 -C 12 )-alkyl] 2 . 10. Process according to claim 1 , wherein the organotetraphosphite used in process step a) has a chlorine content of 1500 ppm to 100 000 ppm. 11. Process according to claim 1 , wherein the purified organotetraphosphite has a chlorine content of <1000 ppm. 12. Process according to claim 1 , where R 1 , R 3 , R 4 are —H. 13. Process according to claim 1 , where R 2 is tert-butyl. 14. Process according to claim 1 , where the organotetraphosphite has one of the structural formulae III, IV, V, VI, VII, VIII, IX, X, XI, XII, XIII, XIV and XV:

Assignees

Inventors

Classifications

  • condensed with carbocyclic or heterocyclic rings or ring systems · CPC title

  • Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring · CPC title

  • the molecule containing more than one cyclic phosphorus atom · CPC title

  • Amides of phosphoric acids · CPC title

  • with hydroxyaryl compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10011619B2 cover?
Universally usable process for reducing the chlorine content of organotetraphosphites.
Who is the assignee on this patent?
Evonik Degussa Gmbh
What technology area does this patent fall under?
Primary CPC classification C07F9/65744. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).